Prep

Free courses, scholarships and research funding with real deadlines — apply before they close.

search
public

219 open opportunities

payments
Oct 16

Fiscal Year 2027 Counter Unmanned Aircraft Systems (C-UAS) Grant Program

Department of Homeland Security - FEMA

Using C-UAS Grant Program funds, eligible governments and their subrecipients may purchase unmanned aircraft system (UAS) Detection, Identifying, Monitoring, Tracking, and Mitigation (DIMT-M) technologies to support public safety officials in the protection of the public and critical infrastructure from nefarious or unlawful use of UAS consistent with 6 U.S.C. § 124n and 6 C.F.R. 124. The operation of certain detection and all mitigation technologies will be limited to accredited law enforcement and correctional agencies that meet the training, certification, accreditation, and authorized technology requirements of 6 C.F.R. 124 described in this Notice of Funding Opportunity (NOFO). For Fiscal Year 2027, the remaining $250 million will be distributed to all 56 states and territories, with a focus on building national detection and response capacity across the nation, generally, as well as an expanded focus on supporting the 2028 Summer Olympics and Paralympics. Crucially, this round of funding must be strategically leveraged to support the Olympic torch relay, representing a vital operational priority to secure the relay's expansive domestic route and ensure seamless interagency coordination before the opening ceremonies. The 2028 Summer Olympics and Paralympics in Los Angeles have been designated as a National Special Security Event (NSSE), and official ancillary events have been designated as Special Event Assessment Rating (SEAR) events. Jurisdictions will receive statutory minimums established under the State Homeland Security Grant Program, with additional funds allocated based on the DHS Terrorism Risk Methodology and the anticipated effectiveness of proposed projects.

eventDeadline: Nov 12 publicUnited States redeemFree
Grants arrow_forward
payments
Oct 15

Specialized Alcohol Research Centers (P50 Clinical trial Optional)

National Institutes of Health

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) supports a broad-based Alcohol Research Centers program to foster and conduct interdisciplinary, collaborative research on alcohol misuse, Alcohol Use Disorder (AUD), and alcohol-related problems, and other health-related consequences across the lifespan. The NIAAA Centers Program provides leadership in research, and research methodology development on a wide variety of topics relevant to the Institute's mission. The focus of the NIAAA Centers program should be on generating a critical mass of researchers in a given understudied and/or innovative topic area relevant to the NIAAA mission with an emphasis on interdisciplinary coordination and cooperation among independent researchers and development and mentorship of young investigators. A center must contribute more to the alcohol field than the sum of its parts. Topics include but are not limited to, the nature, etiology, genetics, diagnosis, treatment, and prevention of alcohol misuse, AUD, alcohol-related end-organ diseases, and their biomedical, psychosocial, and population health consequences across the lifespan. Centers are also major contributors to the development of research methods, technologies, and approaches that sustain innovative goal-directed research on understanding the chronic disorder of alcohol misuse that is such a personal, social and medical burden to US society.

eventDeadline: Jan 27 publicUnited States redeemFree
Grants arrow_forward
payments
Oct 15

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

National Institutes of Health

This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. Through this limited competition Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications to support continuation of two biospecimen banking resources. The National Clinical Trials Network (NCTN) Biospecimen Banks (NCTN Biobanks) support the NCI-funded NCTN and the Community Oncology Research Program (NCORP), and The Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) supports the Experimental Therapeutics Clinical Trials Network (ETCTN) and other NCI-supported early phase and experimental clinical trials. The objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. The goal of these resources is to ensure the availability of biospecimens from participants in NCI-funded clinical trials focused on treatment, prevention, and cancer control studies to enable translational cancer research. The NCTN Biobanks support biomarker development and validation, secondary correlative studies, and broader scientific discovery using biospecimens collected through harmonized protocols and linked to clinical outcome data from large multi-site clinical trials. The EET Biobank supports biospecimen banking for ETCTN and other early-phase and experimental therapeutic clinical trials involving investigational agents. Biospecimens collected through these studies support biomarker assay development, pharmacokinetic and pharmacodynamic analyses, investigation of drug response and resistance mechanisms, patient stratification, and translational research supporting development of novel cancer therapies. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.

eventDeadline: Feb 11 publicUnited States redeemFree
Grants arrow_forward
payments
Oct 15

Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)

National Institutes of Health

The National Center for Complementary and Integrative Health (NCCIH) announces this Notice of Funding Opportunity (NOFO) to solicit applications for multi-site feasibility trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) to reproduce and translate mechanisms of emotional well-being (EWB) into large-scale clinical trials that advance our understanding of whole person health. These early-phase multi-site trials are essential for 1) demonstrating that the mind and body intervention can be delivered with fidelity across sites; 2) demonstrating reproducibility and rigor in engaging targeted mechanisms of EWB by the mind and body intervention across sites; 3) assessing feasibility of participant recruitment and retention, as well as randomization; 4) assessing feasibility of collecting comprehensive clinical (whole person health restoration) and mechanistic (EWB) data across sites; and 5) exploring correlations between changes in mechanistic targets and clinical outcome measurements pooled across sites. By laying this groundwork, studies supported under this NOFO will advance the science of whole person health and prepare the field for rigorous clinical trials and mechanistic mediation analysis with the potential to improve the health and well-being of all Americans.

eventDeadline: Nov 16 publicUnited States redeemFree
Grants arrow_forward